{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:43:03Z","timestamp":1792651383128,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07550-w","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:30:29Z","timestamp":1792650629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond RSV: why the bronchiolitis burden in infants will not simply disappear"],"prefix":"10.1007","volume":"185","author":[{"given":"Francesco","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Buonsenso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"7550_CR1","doi-asserted-by":"publisher","unstructured":"Furgier A, Brehin C, Levy C, Basmaci R, Launay E, Jung C, Assad Z, Lenglart L, Naudin J, Mary AL, Aupiais C, de Pontual L, Biran V, Boutillier B, Hau I, Shum M, Biscardi S, Delestrain C, Toubiana J, Cohen JF, Lambert-Hoffert A, Lorrot M, Romain AS, Ashman M, Yang JS, Prevost B, Corvol H, Basse C, Dubos F, Cotillon M, Bridonneau C, Perceval LM, Bizot E, Fafi I, Portefaix A, Domitien L, Jaillet C, Ouziel A, Titomanlio L, Bechet S, Gajdos V, Gras-Le Guen C, Gillet Y, Cohen R, Jeziorski E, Ouldali N, French Paediatric OVNI Network (2025) Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study. Lancet Reg Health Eur 58:101443. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101443","DOI":"10.1016\/j.lanepe.2025.101443"},{"key":"7550_CR2","doi-asserted-by":"publisher","unstructured":"Guerrero-Del-Cueto F, Lobato-Lopez S, Lozano-Duran D, Sanchez-Duran B, Ramirez-Martin L, Esteban-San-Narciso B, Sosa-Hernandez S, Martin-Pedraz L, Moreno-Perez D, Leiva-Gea I, Nu\u00f1ez-Cuadros E (2025) Assessing the impact of nirsevimab immunization on RSV bronchiolitis hospital admissions and their severity: a case-control study and comparison with pre- and post-COVID-19 seasons in a tertiary pediatric hospital. Pediatr Pulmonol 60(7):e71059. https:\/\/doi.org\/10.1002\/ppul.71059","DOI":"10.1002\/ppul.71059"},{"key":"7550_CR3","doi-asserted-by":"publisher","unstructured":"Touati S, Debs A, Morin L, Jule L, Claude C, Tissieres P, PANDORA study group (2025) Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis. Ann Intensive Care 15(1):56. https:\/\/doi.org\/10.1186\/s13613-025-01460-0","DOI":"10.1186\/s13613-025-01460-0"},{"key":"7550_CR4","doi-asserted-by":"publisher","unstructured":"Hasegawa K, Goto T, Hirayama A, Laham FR, Mansbach JM, Piedra PA, Camargo CA Jr (2019) Respiratory virus epidemiology among us infants with severe bronchiolitis: analysis of 2 multicenter, multiyear cohort studies. Pediatr Infect Dis J 38(8):e180\u2013e183. https:\/\/doi.org\/10.1097\/INF.0000000000002279","DOI":"10.1097\/INF.0000000000002279"},{"key":"7550_CR5","doi-asserted-by":"publisher","unstructured":"Sanz-Mu\u00f1oz I, S\u00e1nchez-de Prada L, Castrodeza-Sanz J, Eiros JM (2024) Microbiological and epidemiological features of respiratory syncytial virus. Rev Esp Quimioter 37(3):209\u2013220. https:\/\/doi.org\/10.37201\/req\/006.2024","DOI":"10.37201\/req\/006.2024"},{"issue":"1","key":"7550_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/infdis\/141.1.98","volume":"141","author":"CB Hall","year":"1980","unstructured":"Hall CB, Douglas RG Jr, Geiman JM (1980) Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 141(1):98\u2013102","journal-title":"J Infect Dis"},{"issue":"4","key":"7550_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2079322","volume":"18","author":"E Baraldi","year":"2022","unstructured":"Baraldi E, Checcucci Lisi G, Costantino C et al (2022) RSV disease in infants and young children: can we see a brighter future? Hum Vaccin Immunother 18(4):2079322. https:\/\/doi.org\/10.1080\/21645515.2022.2079322","journal-title":"Hum Vaccin Immunother"},{"issue":"50","key":"7550_CR8","first-page":"25254","volume":"116","author":"S Nickbakhsh","year":"2019","unstructured":"Nickbakhsh S et al (2019) Virus-virus interactions in the respiratory tract. Proceedings of the National Academy of Sciences (PNAS) 116(50):25254\u201325263","journal-title":"Proceedings of the National Academy of Sciences (PNAS)"},{"issue":"11","key":"7550_CR9","first-page":"1400","volume":"189","author":"KM Kloepfer","year":"2014","unstructured":"Kloepfer KM et al (2014) Viral interference and mucosal immune response in airway epithelium. Am J Respir Crit Care Med 189(11):1400\u20131407","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"7550_CR10","first-page":"1329","volume":"224","author":"K Dee","year":"2021","unstructured":"Dee K et al (2021) Human rhinovirus infection interferes with influenza A virus infection to alter the epidemiology of influenza. J Infect Dis 224(8):1329\u20131338","journal-title":"J Infect Dis"},{"issue":"5","key":"7550_CR11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jmv.21129","volume":"80","author":"JY Chung","year":"2008","unstructured":"Chung JY et al (2008) Respiratory syncytial virus and human metapneumovirus co-infection in children with acute lower respiratory tract infections. J Med Virol 80(5):896\u2013902","journal-title":"J Med Virol"},{"issue":"2","key":"7550_CR12","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1093\/infdis\/jiae467","volume":"232","author":"A Pasanen","year":"2025","unstructured":"Pasanen A, Karjalainen MK, Korppi M, Hallman M, R\u00e4met M, Research Project FinnGen (2025) Genetic susceptibility to acute viral bronchiolitis. J Infect Dis 232(2):e193\u2013e202. https:\/\/doi.org\/10.1093\/infdis\/jiae467","journal-title":"J Infect Dis"},{"issue":"1","key":"7550_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng.2830","volume":"46","author":"K B\u00f8nnelykke","year":"2014","unstructured":"B\u00f8nnelykke K et al (2014) A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 46(1):51\u201355","journal-title":"Nat Genet"},{"issue":"2","key":"7550_CR14","first-page":"606","volume":"143","author":"JL Everman","year":"2019","unstructured":"Everman JL et al (2019) Functional genomics of the 17q21 asthma locus in human airway epithelial cells. J Allergy Clin Immunol 143(2):606\u2013618","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"7550_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1086\/520886","volume":"196","author":"R Janssen","year":"2007","unstructured":"Janssen R, Bont L, Siezen CLE et al (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196(6):826\u2013834","journal-title":"J Infect Dis"},{"issue":"2","key":"7550_CR16","first-page":"327","volume":"93","author":"F Feuillet","year":"2012","unstructured":"Feuillet F et al (2012) Human metapneumovirus infection of airway epithelial cells. J Gen Virol 93(2):327\u2013338","journal-title":"J Gen Virol"},{"issue":"4","key":"7550_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-0031-1283287","volume":"32","author":"JP Lynch","year":"2011","unstructured":"Lynch JP et al (2011) Adenovirus pneumonia in immunocompetent and immunocompromised adults and children. Seminars in Respiratory and Critical Care Medicine 32(4):494\u2013511","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"issue":"23","key":"7550_CR18","first-page":"12644","volume":"86","author":"X Deng","year":"2012","unstructured":"Deng X et al (2012) Human bocavirus 1 infects disease-human airway epithelia and disrupts epithelial barrier function. J Virol 86(23):12644\u201312656","journal-title":"J Virol"},{"issue":"1","key":"7550_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veag002","volume":"12","author":"S Cordela","year":"2026","unstructured":"Cordela S, Harari J, Moirangthem R et al (2026) The S190R mutation in RSV-A F protein impairs nirsevimab binding and neutralization capacity. Virus Evol 12(1):veag002. https:\/\/doi.org\/10.1093\/ve\/veag002","journal-title":"Virus Evol"},{"issue":"9","key":"7550_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70164","volume":"19","author":"M Wetzke","year":"2025","unstructured":"Wetzke M, Le DB, Tometten I et al (2025) Prevalence of resistance-associated mutations in RSV F protein against monoclonal antibodies prior to widespread implementation: findings from a prospective German pediatric cohort. Influenza Other Respir Viruses 19(9):e70164. https:\/\/doi.org\/10.1111\/irv.70164","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"7550_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/cid\/ciae596","volume":"81","author":"D Arbetter","year":"2025","unstructured":"Arbetter D, Gopalakrishnan V, Aksyuk AA et al (2025) Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: analysis from a phase 3 randomized clinical trial (MELODY). Clin Infect Dis 81(3):634\u2013644. https:\/\/doi.org\/10.1093\/cid\/ciae596","journal-title":"Clin Infect Dis"},{"key":"7550_CR22","doi-asserted-by":"publisher","unstructured":"Furgier A, Brehin C, Levy C et al (2025) Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study. Lancet Reg Health Eur 58:101443. Published 2025 Sep 10. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101443","DOI":"10.1016\/j.lanepe.2025.101443"},{"issue":"10340","key":"7550_CR23","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2019","unstructured":"Li Y, Wang X, Blau DM et al (2019) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 399(10340):2047\u20132064. https:\/\/doi.org\/10.1016\/S0140-6736(22)00478-0","journal-title":"Lancet"},{"issue":"6","key":"7550_CR24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-064748","volume":"153","author":"S Schnyder Ghamloush","year":"2024","unstructured":"Schnyder Ghamloush S, Essink B, Hu B et al (2024) Safety and immunogenicity of an mRNA-based hMPV\/PIV3 combination vaccine in seropositive children. Pediatrics 153(6):e2023064748. https:\/\/doi.org\/10.1542\/peds.2023-064748","journal-title":"Pediatrics"},{"issue":"4","key":"7550_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf160","volume":"12","author":"C Shapiro","year":"2025","unstructured":"Shapiro C, S\u00e1nchez-Crespo N, Ciarlet M et al (2025) A randomized phase 1 clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-75 years of age. Open Forum Infect Dis 12(4):ofaf160. https:\/\/doi.org\/10.1093\/ofid\/ofaf160","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"7550_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/v17081140","volume":"17","author":"N Principi","year":"2025","unstructured":"Principi N, Fainardi V, Esposito S (2025) Human metapneumovirus: a narrative review on emerging strategies for prevention and treatment. Viruses 17(8):1140. https:\/\/doi.org\/10.3390\/v17081140","journal-title":"Viruses"},{"key":"7550_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/25151355241310601","volume":"13","author":"K Kelleher","year":"2025","unstructured":"Kelleher K, Subramaniam N, Drysdale SB (2025) The recent landscape of RSV vaccine research. Ther Adv Vaccines Immunother 13:25151355241310601. https:\/\/doi.org\/10.1177\/25151355241310601","journal-title":"Ther Adv Vaccines Immunother"},{"key":"7550_CR28","doi-asserted-by":"crossref","unstructured":"Shan S, Zhang W, Gao H et al (2024) Global seasonal activities of respiratory syncytial virus before the coronavirus disease 2019 pandemic: a systematic review. Open Forum Infect Dis 11(5):ofae238","DOI":"10.1093\/ofid\/ofae238"},{"issue":"12","key":"7550_CR29","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0149-2918(02)80093-5","volume":"24","author":"AS Monto","year":"2002","unstructured":"Monto AS (2002) The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther 24(12):1987\u20131997","journal-title":"Clin Ther"},{"issue":"11","key":"7550_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15585\/mmwr.mm7411a1","volume":"74","author":"NB Jobe","year":"2025","unstructured":"Jobe NB, Rose E, Winn AK, Goldstein L, Schneider ZD, Silk BJ (2025) Human metapneumovirus seasonality and co-circulation with respiratory syncytial virus - United States, 2014-2024. MMWR Morb Mortal Wkly Rep 74(11):182\u2013187. https:\/\/doi.org\/10.15585\/mmwr.mm7411a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"7550_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28350","volume":"10","author":"MA Farrag","year":"2024","unstructured":"Farrag MA, Aziz IM, Alsaleh AN, Almajhdi FN (2024) Human bocavirus in Saudi Arabia: molecular epidemiology and co-infections among children with acute respiratory tract infections during 2014-2016. Heliyon 10(7):e28350. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28350","journal-title":"Heliyon"},{"key":"7550_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128345","volume":"77","author":"M Davis","year":"2026","unstructured":"Davis M, Shapiro C, Ciarlet M et al (2026) A phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60-85 years of age. Vaccine 77:128345. https:\/\/doi.org\/10.1016\/j.vaccine.2026.128345","journal-title":"Vaccine"},{"issue":"7","key":"7550_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013312","volume":"21","author":"A Young","year":"2025","unstructured":"Young A, Kolekar S, Mendoza CA et al (2025) A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. PLoS Pathog 21(7):e1013312. https:\/\/doi.org\/10.1371\/journal.ppat.1013312","journal-title":"PLoS Pathog"},{"issue":"12","key":"7550_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01145-25","volume":"99","author":"S Saul","year":"2025","unstructured":"Saul S, Dahal B, Luongo C, Liu X, Yang L, Santos C, Dai J, Zhang L, Buchholz UJ, Munir S (2025) Intranasal bovine\/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters. J Virol 99(12):e0114525. https:\/\/doi.org\/10.1128\/jvi.01145-25","journal-title":"J Virol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07550-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:30:31Z","timestamp":1792650631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07550-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7550"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07550-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"29 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Claude for image generation and editing the English translation of the first draft of the article, which was entirely authors\u2019 opinion, ideas, and views. The authors reviewed and edited the output as needed and take full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.M. and D.B. participated as sub-investigators in a trial on monoclonal antibodies for RSV.\u00a0F.M has been a Pfizer dependent working in medical direction since February 2026.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"873"}}